Rapid Readouts: The Phase 1/2 ANCHOR Trial for Melphalan Flufenamide in Relapsed/Refractory Multiple Myeloma

Video

Related Videos
Sundar Jagannath, MBBS
Lori A. Leslie, MD
James Ignatz-Hoover, MD, PhD
Changchun Deng, MD, PhD
Sundar Jagannath, MBBS
Elias Jabbour, MD
Guenther Koehne, MD, PhD
Joseph G. Jurcic, MD